rs4950928

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The ENST00000946568.1(CHI3L1):c.-131C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Note: ENST00000946568.1 is not a MANE Select or MANE Plus Clinical transcript for CHI3L1; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The gene CHI3L1 is a known oncogene (CancerMine: 7 oncogene, 2 driver citations). The gene CHI3L1 is a cancer driver gene (CancerMine: 7 oncogene, 2 driver citations). The variant allele was found at a cumulative frequency of 0.791 (AC=808,932) in the gnomAD database across 1,023,164 control chromosomes, including 321,325 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.856. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Variant has been reported in ClinVar as Uncertain Significance (no review stars).

Frequency

Genomes: 𝑓 0.77 ( 44807 hom., cov: 30)
Exomes 𝑓: 0.79 ( 276518 hom. )

Consequence

CHI3L1
ENST00000946568.1 5_prime_UTR

Scores

3

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: -0.968

Publications

153 publications found
Variant links:
Genes affected
CHI3L1 (HGNC:1932): (chitinase 3 like 1) Chitinases catalyze the hydrolysis of chitin, which is an abundant glycopolymer found in insect exoskeletons and fungal cell walls. The glycoside hydrolase 18 family of chitinases includes eight human family members. This gene encodes a glycoprotein member of the glycosyl hydrolase 18 family. The protein lacks chitinase activity and is secreted by activated macrophages, chondrocytes, neutrophils and synovial cells. The protein is thought to play a role in the process of inflammation and tissue remodeling. [provided by RefSeq, Sep 2009]
CHI3L1 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000946568.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.856 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000946568.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CHI3L1 NM_001276.4
MANE Select
HGVSc / HGVSpc.-131C>G
Exon rankN/A
upstream_gene
Prot: NP_001267.2UniProt: P36222

Ensembl Transcripts

CHI3L1 ENST00000946568.1
HGVSc / HGVSpc.-131C>G
Exon rankExon 1 of 10
5_prime_UTR
Prot: ENSP00000616627.1UniProt: A0ACI8UDS9
CHI3L1 ENST00000255409.8
TSL:1MANE Select
HGVSc / HGVSpc.-131C>G
Exon rankN/A
upstream_gene
Prot: ENSP00000255409.3UniProt: P36222
CHI3L1 ENST00000874779.1
HGVSc / HGVSpc.-131C>G
Exon rankN/A
upstream_gene
Prot: ENSP00000544838.1UniProt: A0ACI8R3Y5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.766
AC:116321
Hom:44781
AN:151856
Cov:30
GnomAD4 exome
AF: 0.795
AC:692534
Hom:276518
AN:871190
Cov:11
GnomAD4 genome
AF: 0.766
AC:116398
Hom:44807
AN:151974
Cov:30
TOPMed (Bravo)
AF: 0.772
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.681
AC:7804
Hom:2874
AN:11468
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.818
AC:1913
Hom:787
AN:2340
ChinaMAP Phase 1
AF: 0.848
Denmark Genome
AF: 0.810
AC:243
AN:300
GenomeAsia100K
AF: 0.793
AC:2759
AN:3478
Korea4K (4,157 Koreans)
AF: 0.850
AC:6148
AN:7230
Qatari Genome
AF: 0.881
AC:155
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.850
AC:104348
Hom:44393
AN:122752
Turkish Variome
AF: 0.836
AC:1291
Hom:545
AN:1544
UK10K
AF: 0.797
AC:6030
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.847
AC:7590
Hom:3225
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.646 4940176424 0.655 88280134696
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:risk factor
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Asthma-related traits, susceptibility to, 7 (1)

Computational Scores

AlphaGenome AVI
Benign9.6
BayesDel_noAF
Benign-0.90
CADD
Benign0.74
DANN
Benign0.47
GPN-Star LLR
N/A1.5
GPN-Star score
N/A-1.4
PhyloP100
Benign-0.97
PromoterAI
N/A-0.056Neutral
Showing 8 of 8 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.